Siyan Clinical Corporation

What Siyan Clinical Corporation does

Siyan Clinical Corporation is a private, for-profit scientific research firm headquartered in Santa Rosa, California, that conducts psychiatric clinical studies in an outpatient setting. Founded in 2012, the company operates in the clinical research site / site management organization (SRO) segment of the drug development value chain, providing the infrastructure, patient recruitment, principal investigator oversight, and protocol execution capabilities required to run psychiatry trials outside of a hospital environment. Its functional role is to serve as a study site — and potentially a site network — for pharmaceutical and biotechnology sponsors outsourcing psychiatric Phase I-IV research, with its outpatient model implying a focus on indications such as depression, anxiety, schizophrenia, bipolar disorder, ADHD, or substance use disorders where daily inpatient monitoring is unnecessary.

The company is small, with a stated headcount range of 11-50 employees, consistent with a single-site or small multi-site specialty research operation rather than a scaled CRO platform. There is no disclosed proprietary technology stack, no named data platform, and no productized offering beyond clinical study conduct itself. Its technology footprint appears limited to standard clinical research tooling (EDC, eTMF, IxRS) typical of any clinical site. The corporate website (siyanclinical.com) returned only a verification loading screen during data collection, indicating no public-facing marketing, investor, or product narrative was available at the time of sourcing.

The revenue model is consistent with a fee-for-service clinical research site: sponsors pay per protocol, per patient visit, or per milestone for executing study procedures, with revenue mechanics driven by trial volume, enrollment throughput, and per-patient budgets negotiated with biopharma clients. No publicly disclosed pricing, contract structures, customer logos, or funding history were available, and no parent company, subsidiaries, or ownership structure were identified. The lack of disclosed capital raises suggests the firm has been funded through operating cash flow rather than institutional investment.

Name

Siyan Clinical Corporation

Website

https://siyanclinical.com

Company type

Private

Founded year

2012

Headcount range

11–50 employees

Short description

Siyan Clinical Corporation is a private, for-profit clinical research firm founded in 2012 in Santa Rosa, California, that conducts psychiatric outpatient studies for pharmaceutical and biotechnology sponsors. The firm operates as a small specialty research site organization with 11-50 employees.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAFACAA

Outpatient Mental Health Clinics & Counseling Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

Keywords

• Psychiatric clinical research
• Outpatient clinical trials
• Clinical study management
• Psychiatry research services
• Scientific research services

Headquarters

HQ city

Santa Rosa

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Siyan Clinical Corporation is a scientific research firm that conducts psychiatric clinical studies in outpatient settings. The company executes clinical research protocols for psychiatric indications, operating as a site-based clinical research organization rather than developing therapeutics or technology products of its own.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Psychiatric Clinical Studies Scientific research services conducting psychiatric clinical studies in outpatient settings for sponsor clients (pharmaceutical, biotech, and CRO organizations) seeking community-based psychiatric trial execution.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Elligo Health Research: Elligo is a larger, multi-therapeutic clinical research site network that brings trials into outpatient and community-based settings via its Goes Direct platform. It is comparable to Siyan in its use of outpatient delivery, but operates at significantly greater scale across many therapeutic areas.
• Care Access Research: Care Access operates decentralized and site-based clinical research infrastructure across many therapeutic areas, including CNS. It competes with Siyan for outpatient psychiatric study placement but at a national scale with significantly more resources.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a global CRO with significant CNS and psychiatry franchise and an investigator-site network. It is comparable in therapeutic focus but operates as a full-service CRO rather than a standalone site.
• CenExel: CenExel is a network of clinical research sites with strong CNS and psychiatry capabilities among its therapeutic centers. It is comparable as an outpatient/early-phase site operator focused partly on psychiatric trials, but operates at much greater scale and with broader therapeutic coverage.
• Velocity Clinical Research: Velocity is a large, multi-site clinical research organization operating dedicated research sites across multiple therapeutic areas in the U.S. It competes with Siyan for sponsor study awards but offers a substantially broader site footprint and therapeutic coverage.

Direct peers

• Hassman Research Institute (HRI): HRI is a clinical research site organization that specializes in psychiatric and CNS clinical trials across outpatient and inpatient settings. It is the closest direct comparable to Siyan in therapeutic focus (psychiatry) and operating model (dedicated research site), differing mainly in geographic footprint.
• CBH Health: CBH Health operates psychiatric clinical research sites conducting outpatient and inpatient CNS trials. Like Siyan, it focuses specifically on psychiatric indications as a dedicated site network, making it a closely comparable peer in trial focus and delivery model.
• Praxis Research: Praxis Research is a multi-specialty clinical research site organization that conducts outpatient trials, with psychiatry and CNS among its therapeutic focus areas. It is directly comparable to Siyan in operating model and therapeutic emphasis.

Emerging players

• Apex Innovative Sciences: Apex operates early-phase and specialty clinical research sites, including CNS and psychiatry exposure. It is comparable to Siyan in site-based clinical research delivery and outpatient orientation, though it spans broader early-phase capabilities.

Others

• Clincierge: Clincierge provides patient logistics and concierge services that support enrollment and retention in clinical trials, including CNS studies. It is thematically related to Siyan's outpatient psychiatric trial delivery but serves as an enabling service provider rather than a direct site competitor.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siyan Clinical Corporation